Completed PHASE2 INTERVENTIONAL 2-arm NCT00661492

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

A Randomized Phase II Study of Mitoxantrone vs. Mitoxantrone With Cetuximab in Metastatic Androgen Independent Prostate Cancer (AIPC) Previously Treated With Docetaxel-based Chemotherapy

Sponsor: Eli Lilly and Company

Conditions Androgen-independent Prostate Cancer

Interventions Mitoxantrone cetuximab

Updated 8 times since 2017 Last updated: Oct 13, 2016 Started: May 31, 2008 Primary completion: Mar 31, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Androgen-independent Prostate Cancer, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 8 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Nov 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Nov 2019 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eli Lilly and Company
Oregon Health and Science University
US Oncology Research

Data source: US Oncology Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Amarillo, United States , Arlington, United States , Austin, United States , Beaumont, United States , Burien, United States , Columbia, United States , Dallas, United States , Denton, United States , Denver, United States and 42 more locations